Guidelines Posts on Medivizor
Navigation Menu

Guidelines Posts on Medivizor

Managing patients with chronic myeloid leukemia who fail responding to second generation tyrosine kinase inhibitors

Managing patients with chronic myeloid leukemia who fail responding to second generation tyrosine kinase inhibitors

Posted by on Jun 7, 2020 in Leukemia | 0 comments

In a nutshell The report recommends how to manage patients with chronic-phase chronic myeloid leukemia (CP-CML) who failed to respond to 2nd generation tyrosine kinase inhibitors (TKIs). The authors suggested to consider patient-specific factors and personalize treatment for such patients. Some background TKIs deactivate cancerous enzymes which cause...

Read More

Update regarding the treatment options for patients with Hodgkin lymphoma

Update regarding the treatment options for patients with Hodgkin lymphoma

Posted by on Jun 6, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This article reviewed the current treatment options for patients with Hodgkin lymphoma (HL). Some background Treatment options for patients with HL depend on the type of HL, stage of the disease, and the presence of risk factors. The stage of HL represents how widespread or severe the cancer is. Risk factors indicate that there...

Read More

Reviewing treatments for unexplained infertility

Posted by on Apr 14, 2020 in Infertility | 0 comments

In a nutshell This review established recommendations for the treatment of unexplained infertility.  Some background There is no clear cause for up to 30% of infertility cases. There are several treatment options for these couples. Expectant management uses intercourse to achieve conception. Ovarian stimulation (OS) treatment...

Read More

NCCN guidelines for acute myeloid leukemia

Posted by on Mar 27, 2020 in Leukemia | 0 comments

In a nutshell These guidelines aimed to provide the latest guidelines on managing acute myeloid leukemia.   Some background Acute myeloid leukemia (AML) is the most common form of acute leukemia in adults. Recent advances have led to new treatment options for AML such as targeted therapies and low-intensity...

Read More

Reviewing treatment options for patients with uveal melanoma

Posted by on Mar 13, 2020 in Melanoma | 0 comments

In a nutshell This guideline reviewed treatment options for patients with newly diagnosed uveal melanoma. Some background The uvea is the middle layer of the eye. It is made up of the iris (the colored part of the eye), the ciliary body (a muscle in the eye), and the choroid (a layer of tissue in the back of the eye). In uveal melanoma (UM), tumors...

Read More

Benefits of therapy for early stage breast cancer

Posted by on Feb 29, 2020 in Breast cancer | 0 comments

In a nutshell This paper is a document that was developed at a breast cancer conference by a number of experts in the field. It outlines suggested treatment for early-stage breast cancer. The experts concluded that patients and doctors should work together and discuss the benefit of treating early-stage breast cancer in comparison with the potential...

Read More